PL4330662T3 - Analityczna hplc - Google Patents

Analityczna hplc

Info

Publication number
PL4330662T3
PL4330662T3 PL22725757.3T PL22725757T PL4330662T3 PL 4330662 T3 PL4330662 T3 PL 4330662T3 PL 22725757 T PL22725757 T PL 22725757T PL 4330662 T3 PL4330662 T3 PL 4330662T3
Authority
PL
Poland
Prior art keywords
analytical hplc
hplc
analytical
Prior art date
Application number
PL22725757.3T
Other languages
English (en)
Inventor
Alan Clarke
Hendrik Petrus ENGELBRECHT
Julian Grigg
Imtiaz Ahmed Khan
Kristine WIKENE
Graeme Mcrobbie
Original Assignee
Ge Healthcare Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Limited filed Critical Ge Healthcare Limited
Publication of PL4330662T3 publication Critical patent/PL4330662T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/34Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/0093Radioactive materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N2030/022Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027Liquid chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/884Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds
    • G01N2030/8845Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds involving halogenated organic compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8859Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample inorganic compounds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
PL22725757.3T 2021-04-26 2022-04-26 Analityczna hplc PL4330662T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2105950.6A GB202105950D0 (en) 2021-04-26 2021-04-26 Analytical HPLC
PCT/EP2022/061004 WO2022229155A1 (en) 2021-04-26 2022-04-26 Analytical hplc

Publications (1)

Publication Number Publication Date
PL4330662T3 true PL4330662T3 (pl) 2025-11-12

Family

ID=76193425

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22725757.3T PL4330662T3 (pl) 2021-04-26 2022-04-26 Analityczna hplc

Country Status (12)

Country Link
US (1) US20240302338A1 (pl)
EP (1) EP4330662B1 (pl)
JP (1) JP2024518319A (pl)
KR (1) KR20240000562A (pl)
CN (1) CN117222890A (pl)
AU (1) AU2022264815A1 (pl)
CA (1) CA3217818A1 (pl)
ES (1) ES3050308T3 (pl)
GB (1) GB202105950D0 (pl)
IL (1) IL307946A (pl)
PL (1) PL4330662T3 (pl)
WO (1) WO2022229155A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201915206D0 (en) 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer
CN119688861A (zh) * 2024-11-29 2025-03-25 中国辐射防护研究院 一种生物样本中18f-psma-1007放化纯的液相色谱分析方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300280A (en) * 1992-02-14 1994-04-05 Mallinckrodt Medical, Inc. Stabilized radiopharmaceutical kits
CA2666005C (en) * 2002-03-01 2016-01-19 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
JP4942953B2 (ja) * 2005-06-30 2012-05-30 サントリーホールディングス株式会社 プロシアニジンの分析方法
US8214159B2 (en) * 2008-12-04 2012-07-03 Siemens Medical Solutions Usa, Inc. Apparatus and method for automated quality control
GB201013808D0 (en) * 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
EP2450332A1 (en) * 2010-10-22 2012-05-09 Bayer Pharma Aktiengesellschaft Compounds for use in Imaging, diagnosing and/or treatment of diseases of the central nervous system (F-D2-Deprenyl)
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
EP2882863B1 (en) * 2012-08-13 2021-07-14 The General Hospital Corporation System and method for quantitative mapping of mitocondrial complex 1
GB201303830D0 (en) * 2013-03-04 2013-04-17 Univ Glasgow Methods,unit and device relating to the manufacture,processing,synthesising or screening of radiopharmaceutical compositions
GB201418893D0 (en) * 2014-10-23 2014-12-10 Univ Hull Monolithic body
GB201805253D0 (en) * 2018-03-29 2018-05-16 Ge Healthcare Ltd Ip Solid phase extraction
CN111333638A (zh) * 2020-03-17 2020-06-26 四川大学华西医院 18f标记的异喹啉并哒嗪酮类化合物及其合成方法和应用

Also Published As

Publication number Publication date
AU2022264815A1 (en) 2023-10-26
US20240302338A1 (en) 2024-09-12
JP2024518319A (ja) 2024-05-01
EP4330662B1 (en) 2025-09-03
CA3217818A1 (en) 2022-11-03
KR20240000562A (ko) 2024-01-02
GB202105950D0 (en) 2021-06-09
WO2022229155A1 (en) 2022-11-03
IL307946A (en) 2023-12-01
EP4330662A1 (en) 2024-03-06
CN117222890A (zh) 2023-12-12
EP4330662C0 (en) 2025-09-03
ES3050308T3 (en) 2025-12-19

Similar Documents

Publication Publication Date Title
EP3668977A4 (en) HPLC ANALYTICAL PROCESSES
CA208524S (en) Soundbar
DK4305181T3 (en) Minimal nefrin-promotor
GB2600728B (en) Dual-comb spectrometry
CA196956S (en) Onesie
CA207519S (en) Smartglasses
CA207517S (en) Smartglasses
CA207516S (en) Smartglasses
CA199411S (en) Handshower
PL4330662T3 (pl) Analityczna hplc
CA200872S (en) Nighstand
GB201910777D0 (en) Analytical method
CA206631S (en) Mandoline
GB202104683D0 (en) Analytical HPLC
GB202215978D0 (en) Analytical HPLC
CA218802S (en) Autosampler carousel
CA204263S (en) Brushguard
CA198107S (en) Protractor-ruler
GB2603239B (en) Autosampler
CA212416S (en) Aéronef
GB202202384D0 (en) Feature n
GB202113947D0 (en) Chromatography column
GB202209846D0 (en) One
CA207518S (en) Smartglasses
CA204910S (en) Volvelle